Latham & Watkins Advises Cryoport in its Public Stock Offering

An Orange County-based team advises the cryogenic logistics solutions company in the offering.

January 25, 2021

Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, has announced the closing of an underwritten public offering of 4,356,059 shares of its common stock, at a public offering price of US$66 per share, which includes 568,181 shares issued following the full exercise by the underwriters of their option to purchase additional shares at the public offering price, before deducting underwriting discounts and commissions.

Latham & Watkins LLP represents Cryoport in the offering with Orange County-based deal team led by partners Daniel Rees and Drew Capurro, with associates Traci Biedermann and Tiana Baghdikian. Advice was also provided on tax matters by New York partner Elena Romanova, with associate Lea Li.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.